Invesco
IMGN

Invesco’s Immunogen Inc IMGN Stock Holding History

Invesco’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-885,323
Closed -$26.2M – 3983
2023
Q4 		$26.2M Sell
885,323
-200,845
-18% -$4M 0.01% 1280
2023
Q3 		$17.2M Buy
1,086,168
+50,463
+5% +$839K ﹤0.01% 1418
2023
Q2 		$19.5M Buy
1,035,705
+853,637
+469% +$10.1M 0.01% 1379
2023
Q1 		$699K Buy
182,068
+90,988
+100% +$388K ﹤0.01% 3089
2022
Q4 		$452K Sell
91,080
-379
-0.4% -$2.06K ﹤0.01% 3321
2022
Q3 		$437K Buy
91,459
+5,062
+6% +$26.7K ﹤0.01% 3319
2022
Q2 		$389K Buy
86,397
+2,110
+3% +$9.17K ﹤0.01% 3462
2022
Q1 		$402K Buy
84,287
+265
+0.3% +$1.47K ﹤0.01% 3504
2021
Q4 		$624K Sell
84,022
-8,219
-9% -$51.1K ﹤0.01% 3294
2021
Q3 		$524K Buy
92,241
+12,010
+15% +$69.4K ﹤0.01% 3408
2021
Q2 		$529K Buy
80,231
+31,449
+64% +$219K ﹤0.01% 3393
2021
Q1 		$395K Buy
48,782
+5,254
+12% +$42.9K ﹤0.01% 3440
2020
Q4 		$281K Buy
43,528
+11,864
+37% +$69.2K ﹤0.01% 3442
2020
Q3 		$114K Sell
31,664
-1,322,736
-98% -$5.34M ﹤0.01% 3566
2020
Q2 		$6.23M Buy
1,354,400
+1,334,164
+6,593% +$5.67M ﹤0.01% 1879
2020
Q1 		$70K Sell
20,236
-386,778
-95% -$1.69M ﹤0.01% 3593
2019
Q4 		$2.08M Buy
+407,014
New +$1.38M ﹤0.01% 2632
2019
Q2 		– Sell
-17,232
Closed -$47K – 3798
2019
Q1 		$47K Buy
17,232
+394
+2% +$1.71K ﹤0.01% 3697
2018
Q4 		$81K Sell
16,838
-3,279
-16% -$19.9K ﹤0.01% 3669
2018
Q3 		$191K Sell
20,117
-227,620
-92% -$2.19M ﹤0.01% 3710
2018
Q2 		$2.41M Sell
247,737
-729,938
-75% -$7.69M ﹤0.01% 2640
2018
Q1 		$10.3M Sell
977,675
-633,203
-39% -$6.25M ﹤0.01% 1519
2017
Q4 		$10.3M Buy
1,610,878
+661,590
+70% +$4.08M ﹤0.01% 1554
2017
Q3 		$7.26M Buy
949,288
+613,102
+182% +$4.07M ﹤0.01% 1753
2017
Q2 		$2.39M Buy
336,186
+323,366
+2,522% +$1.48M ﹤0.01% 2424
2017
Q1 		$50K Buy
12,820
+2,149
+20% +$6.27K ﹤0.01% 3684
2016
Q4 		$22K Buy
+10,671
New +$21.4K ﹤0.01% 3678
2016
Q2 		– Sell
-955,724
Closed -$8.14M – 3733
2016
Q1 		$8.14M Buy
955,724
+110,523
+13% +$935K ﹤0.01% 1528
2015
Q4 		$11.5M Sell
845,201
-119,847
-12% -$1.48M ﹤0.01% 1415
2015
Q3 		$9.26M Sell
965,048
-685,680
-42% -$10M ﹤0.01% 1490
2015
Q2 		$23.7M Buy
+1,650,728
New +$18.1M 0.01% 1136
2014
Q4 		– Sell
-930,633
Closed -$9.86M – 4110
2014
Q3 		$9.86M Buy
+930,633
New +$10.5M ﹤0.01% 1541
2014
Q2 		– Sell
-733,259
Closed -$10.9M – 4098
2014
Q1 		$10.9M Buy
733,259
+183,032
+33% +$2.89M ﹤0.01% 1471
2013
Q4 		$8.07M Buy
550,227
+547,616
+20,973% +$8.42M ﹤0.01% 1691
2013
Q3 		$44K Hold
2,611
– – ﹤0.01% 4098
2013
Q2 		$43K Buy
+2,611
New +$42.3K ﹤0.01% 4065

Other funds holding IMGN

IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
MG
Mather Group Chicago, Illinois $10B AUM 15.14% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Invesco's IMGN Position: Q1 2024 in Review

Invesco sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 885,323 shares — an estimated $26.2M sold.

Invesco first reported a position in IMGN in Q2 2013 and held it in 36 quarters. The position peaked at $26.2M in Q4 2023. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.

  • Invesco reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
  • Invesco sold 885,323 Immunogen Inc shares in Q1 2024, an estimated $26.2M.
  • Invesco first reported a position in Immunogen Inc in Q2 2013 and held it in 36 quarters.
  • Invesco's Immunogen Inc position peaked at $26.2M in Q4 2023.
  • 3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.

Based on Invesco's 13F filing for Q1 2024, filed 14 May 2024.